From Discovery to Clinical Impact: How Advanced Imaging Is Transforming Drug Development email

From Discovery to Clinical Impact: How Advanced Imaging Is Transforming Drug Development

Dear Kenneth,

Advanced imaging is moving beyond a supporting role in drug development. As technologies become more sophisticated and accessible, imaging is helping teams generate quantitative, non-invasive insights that can inform safety, dosing, efficacy and translational decision-making.

A new executive summary from a CMIC and Citeline roundtable brings together expert perspectives on how imaging is being applied across discovery, preclinical and clinical development.

This discussion explores:

How imaging can support biomarker-led development strategies
Why PET, MRI, theranostics and functional imaging are gaining attention
How imaging can help inform go/no-go decisions earlier in development
The operational and infrastructure challenges limiting broader adoption
Why collaboration between sponsors, CROs and imaging partners is essential

Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.

By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).